dihydroxyphenylalanine has been researched along with Cerebrovascular Disorders in 14 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with dystonia only, dopaminergic lesions were mostly confined to the ventromesial mesencephalon and red nucleus area, including the substantia nigra and nigrostriatal and cerebellothalamic fibers." | 5.30 | Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography. ( Agid, Y; Dormont, D; Dupel, C; Jedynak, P; Lehéricy, S; Marsault, C; Remy, P; Samson, Y; Serdaru, M; Veber, H; Vidailhet, M, 1999) |
| "In patients with dystonia only, dopaminergic lesions were mostly confined to the ventromesial mesencephalon and red nucleus area, including the substantia nigra and nigrostriatal and cerebellothalamic fibers." | 1.30 | Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography. ( Agid, Y; Dormont, D; Dupel, C; Jedynak, P; Lehéricy, S; Marsault, C; Remy, P; Samson, Y; Serdaru, M; Veber, H; Vidailhet, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (92.86) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vidailhet, M | 1 |
| Dupel, C | 1 |
| Lehéricy, S | 1 |
| Remy, P | 1 |
| Dormont, D | 1 |
| Serdaru, M | 1 |
| Jedynak, P | 1 |
| Veber, H | 1 |
| Samson, Y | 1 |
| Marsault, C | 1 |
| Agid, Y | 1 |
| Gehlen, W | 1 |
| Van Woert, MH | 1 |
| Weintraub, MI | 1 |
| Araki, S | 1 |
| Kameyama, M | 1 |
| Matthews, WB | 1 |
| Booker, HE | 1 |
| Dahl, DS | 1 |
| Yahr, MD | 1 |
| Hamoen, AM | 1 |
| Nicholson, WJ | 1 |
| Bellastella, A | 1 |
| Cafaro, MR | 1 |
| Colucci, CF | 1 |
| D'Alessandro, B | 1 |
| Gasbarro, R | 1 |
| Atarashi, J | 1 |
| Terashi, A | 1 |
| Gisselmann, A | 1 |
| Lacroix, B | 1 |
| Lamy, A | 1 |
| Loche, D | 1 |
6 reviews available for dihydroxyphenylalanine and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Iatrogenic damage possibilities in the drug therapy of neurologic and psychiatric diseases].
Topics: Amantadine; Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Central Nervous System Di | 1977 |
[Recent trend in neurology].
Topics: Cerebrovascular Disorders; Demyelinating Diseases; Diet Therapy; Dihydroxyphenylalanine; Epilepsy; H | 1970 |
[Neurology].
Topics: Autonomic Nervous System; Brain Diseases; Cerebrovascular Disorders; Demyelinating Diseases; Dihydro | 1972 |
Advances in neurology.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticoagulants; Anticonvulsants; Antihypertens | 1972 |
L-dopa in neurological disease: current status.
Topics: Aged; Amyotrophic Lateral Sclerosis; Basal Ganglia Diseases; Cerebellar Diseases; Cerebrovascular Di | 1972 |
[Recent progress in neurology].
Topics: Abdomen; Brain Death; Cerebrovascular Disorders; Demyelinating Diseases; Diffuse Cerebral Sclerosis | 1971 |
8 other studies available for dihydroxyphenylalanine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography.
Topics: Adolescent; Aged; Cerebellum; Cerebrovascular Disorders; Corpus Striatum; Dihydroxyphenylalanine; Do | 1999 |
Predicting the response to levodopa.
Topics: Calcinosis; Capillaries; Central Nervous System; Cerebrospinal Fluid; Cerebrovascular Disorders; Dih | 1971 |
Clinical neurology.
Topics: Basal Ganglia; Cerebrovascular Disorders; Coma; Diagnosis, Differential; Dihydroxyphenylalanine; Hum | 1971 |
Possible association between triphasic E.E.G. waves and disorder of dopaminergic systems.
Topics: Amantadine; Cerebrovascular Disorders; Creutzfeldt-Jakob Syndrome; Dihydroxyphenylalanine; Dopamine; | 1973 |
Medicine in old age. Diseases of the motor system.
Topics: Activities of Daily Living; Aged; Basal Ganglia Diseases; Brain Stem; Bulbar Palsy, Progressive; Cer | 1973 |
[Behavior of plasmatic HGH after stimulation with L-Dopa in normal elderly subjects and in subjects with cerebrovascular disorders: preliminary study].
Topics: Adult; Age Factors; Aged; Aging; Cerebrovascular Disorders; Dihydroxyphenylalanine; Growth Hormone; | 1973 |
[L Dopa and neurologic comas].
Topics: Adult; Aged; Cerebrovascular Disorders; Coma; Dihydroxyphenylalanine; Electroencephalography; Female | 1972 |
A second report on Levodopa.
Topics: Amantadine; Arrhythmias, Cardiac; Cerebrovascular Disorders; Dihydroxyphenylalanine; Humans; Hypoten | 1969 |